HK1246657A1 - 具有祖先序列的因子viii蛋白、表達載體和與其相關的用途 - Google Patents
具有祖先序列的因子viii蛋白、表達載體和與其相關的用途Info
- Publication number
- HK1246657A1 HK1246657A1 HK18106190.5A HK18106190A HK1246657A1 HK 1246657 A1 HK1246657 A1 HK 1246657A1 HK 18106190 A HK18106190 A HK 18106190A HK 1246657 A1 HK1246657 A1 HK 1246657A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- expression vectors
- factor viii
- uses related
- viii proteins
- ancestral sequences
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562109964P | 2015-01-30 | 2015-01-30 | |
PCT/US2016/015092 WO2016123200A1 (en) | 2015-01-30 | 2016-01-27 | Factor viii proteins having ancestral sequences, expression vectors, and uses related thereto |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1246657A1 true HK1246657A1 (zh) | 2018-09-14 |
Family
ID=56544270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18106190.5A HK1246657A1 (zh) | 2015-01-30 | 2018-05-14 | 具有祖先序列的因子viii蛋白、表達載體和與其相關的用途 |
Country Status (5)
Country | Link |
---|---|
US (3) | US10654910B2 (zh) |
EP (1) | EP3250226B1 (zh) |
ES (1) | ES2819123T3 (zh) |
HK (1) | HK1246657A1 (zh) |
WO (1) | WO2016123200A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2819123T3 (es) | 2015-01-30 | 2021-04-15 | Univ Emory | Proteínas del factor VIII que tienen secuencias ancestrales, vectores de expresión, y usos relacionados con ellos |
US10894960B2 (en) | 2016-08-30 | 2021-01-19 | Children's Hospital Medical Center | Compositions and methods for nucleic acid transfer |
EP3622065A1 (en) | 2017-05-09 | 2020-03-18 | Emory University | Clotting factor variants and their use |
US20200347116A1 (en) * | 2017-11-01 | 2020-11-05 | Queen's University At Kingston | Von willebrand factor proteins for treating bleeding disorders |
EP3775194B1 (en) | 2018-04-12 | 2023-06-28 | Biotest AG | De-immunized factor viii molecule and pharmaceutical compositions comprising the same |
EP3773690A1 (en) * | 2018-04-13 | 2021-02-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New vaccinal strategy |
US10842885B2 (en) | 2018-08-20 | 2020-11-24 | Ucl Business Ltd | Factor IX encoding nucleotides |
WO2020168362A1 (en) | 2019-02-15 | 2020-08-20 | Crispr Therapeutics Ag | Gene editing for hemophilia a with improved factor viii expression |
EP3962532A4 (en) * | 2019-04-29 | 2023-06-14 | Children's Hospital Medical Center | COMPOSITIONS WITH OPTIMIZED LIGAND AND METHODS OF USE THEREOF |
WO2021043757A1 (en) | 2019-09-02 | 2021-03-11 | Biotest Ag | Factor viii protein with increased half-life |
WO2023092864A1 (en) * | 2021-11-25 | 2023-06-01 | Sichuan Real&Best Biotech Co., Ltd. | Engineered human fviii with enhanced secretion ability and clotting activity |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003100053A1 (en) * | 2002-05-22 | 2003-12-04 | The Children's Hospital Of Philadelphia | Compositions and methods for the treatment of hemophilia a |
EP1424344A1 (en) * | 2002-11-29 | 2004-06-02 | Aventis Behring Gesellschaft mit beschränkter Haftung | Modified cDNA factor VIII and its derivates |
US8637448B2 (en) * | 2010-09-14 | 2014-01-28 | University Of Rochester | Recombinant factor VIII having enhanced stability following mutation at the A1-C2 domain interface |
MY165089A (en) * | 2010-11-05 | 2018-02-28 | Baxalta Inc | A new variant of antihemophilic factor viii having increased specific activity |
US10370430B2 (en) | 2012-02-15 | 2019-08-06 | Bioverativ Therapeutics Inc. | Recombinant factor VIII proteins |
ES2819123T3 (es) | 2015-01-30 | 2021-04-15 | Univ Emory | Proteínas del factor VIII que tienen secuencias ancestrales, vectores de expresión, y usos relacionados con ellos |
-
2016
- 2016-01-27 ES ES16744021T patent/ES2819123T3/es active Active
- 2016-01-27 WO PCT/US2016/015092 patent/WO2016123200A1/en active Application Filing
- 2016-01-27 US US15/547,742 patent/US10654910B2/en active Active
- 2016-01-27 EP EP16744021.3A patent/EP3250226B1/en active Active
-
2018
- 2018-05-14 HK HK18106190.5A patent/HK1246657A1/zh unknown
-
2020
- 2020-05-14 US US16/874,121 patent/US11046750B2/en active Active
-
2021
- 2021-06-23 US US17/355,656 patent/US11897938B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US11897938B2 (en) | 2024-02-13 |
EP3250226A4 (en) | 2018-10-03 |
EP3250226B1 (en) | 2020-07-15 |
EP3250226A1 (en) | 2017-12-06 |
US11046750B2 (en) | 2021-06-29 |
US20200277356A1 (en) | 2020-09-03 |
US20180009873A1 (en) | 2018-01-11 |
US20210388055A1 (en) | 2021-12-16 |
ES2819123T3 (es) | 2021-04-15 |
US10654910B2 (en) | 2020-05-19 |
WO2016123200A1 (en) | 2016-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1246657A1 (zh) | 具有祖先序列的因子viii蛋白、表達載體和與其相關的用途 | |
IL282168A (en) | Factor VIII chimeric proteins and their uses | |
LT3872085T (lt) | Viruso prototipo sekos ir jų panaudojimas | |
HK1251612A1 (zh) | 包含2a肽的重組載體 | |
GB201715052D0 (en) | Vectors | |
IL265942A (en) | A nucleotide sequence expressing an exosome anchor protein for use as a component | |
GB201607534D0 (en) | Peptides | |
GB201717524D0 (en) | Vectors | |
ZA201901942B (en) | Nnif and nnif-related peptides and related methods | |
GB201604468D0 (en) | Peptides | |
PL3609348T3 (pl) | Teksturowany produkt białkowy | |
PT3440208T (pt) | Vetores para clonagem e expressão de proteínas, métodos e suas aplicações | |
ZA202003722B (en) | Modified globin proteins | |
GB2558968B (en) | G Proteins | |
GB201612150D0 (en) | Modified peptide | |
GB201607535D0 (en) | Peptides | |
IL274278A (en) | vectors | |
ZA201905544B (en) | Modified haemoglobin proteins | |
GB201406705D0 (en) | Fusion proteins,polynucleotides,expression vectors, and their uses | |
GB201711971D0 (en) | Vectors | |
GB201711620D0 (en) | Peptides | |
GB201707837D0 (en) | Peptides | |
GB201617925D0 (en) | Proteins and uses | |
GB201612665D0 (en) | Peptides | |
GB201608820D0 (en) | Peptides |